POINT BIOPHARMA GLOBAL INC. Operating Cash Flow
POINT BIOPHARMA GLOBAL INC. reported Operating Cash Flow of -$124.86 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$28.13M.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$74.34M.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$22.39M.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was $236.92M.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) operating activities for fiscal 2022 was $183.52M.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) operating activities for fiscal 2021 was -$44.70M.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) operating activities for fiscal 2020 was -$8.30M.
| Period end | Net Cash Provided by (Used in) Operating Activities 2 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | -$28.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$102.47M derived: sum of 2 quarters · filed 2023-11-13 | -$124.86M 10-Q · filed 2023-11-13 | $112.06M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2023-06-30 | -$74.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$96.73M 10-Q · filed 2023-08-14 | $140.19M derived: sum of 3 quarters · filed 2023-08-14 | $117.86M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2023-03-31 | -$22.39M 10-Q · filed 2023-05-15 | $214.52M derived: sum of 2 quarters · filed 2023-05-15 | $192.20M derived: sum of 3 quarters · filed 2023-11-13 | $171.62M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-12-31 | $236.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $214.59M derived: sum of 2 quarters · filed 2023-11-13 | $194.01M derived: sum of 3 quarters · filed 2023-11-13 | $183.52M 10-K · filed 2023-03-27 | ||||
| 2022-09-30 | -$22.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$42.91M derived: sum of 2 quarters · filed 2023-11-13 | -$53.40M 10-Q · filed 2023-11-13 | -$64.92M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$20.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$31.07M 10-Q · filed 2023-08-14 | -$42.60M derived: sum of 3 quarters · filed 2023-08-14 | -$56.32M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$10.49M 10-Q · filed 2023-05-15 | -$22.02M derived: sum of 2 quarters · filed 2023-05-15 | -$35.74M derived: sum of 3 quarters · filed 2023-05-15 | -$44.22M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$11.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$25.25M derived: sum of 2 quarters · filed 2023-03-27 | -$33.73M derived: sum of 3 quarters · filed 2023-03-27 | -$44.70M 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | -$13.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$22.20M derived: sum of 2 quarters · filed 2022-11-14 | -$33.17M 10-Q · filed 2022-11-14 | -$31.39M 10-Q · filed 2021-11-12 | -$33.22M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$8.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$19.44M 10-Q · filed 2022-08-12 | -$16.83M 10-Q · filed 2021-08-13 | -$19.49M derived: sum of 3 quarters · filed 2022-08-12 | -$19.07M derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | -$10.97M 10-Q · filed 2022-05-13 | -$395.02K 10-Q · filed 2021-04-29 | -$11.01M derived: sum of 2 quarters · filed 2022-05-13 | -$10.59M derived: sum of 3 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$46.77K derived: 10-K 9 month − 10-Q 6 month · filed 2021-03-04 | $374.75K derived: sum of 2 quarters · filed 2021-11-12 | -$306.54K 10-K · filed 2021-03-04 | -$8.30M 10-K · filed 2022-03-25 | ||||
| 2020-09-30 | $421.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$259.76K 10-Q · filed 2020-11-02 | -$3.79M 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | -$18.01K 10-Q · filed 2020-08-20 | -$4.21M 10-Q · filed 2021-08-13 |